Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 3
1950 1
1951 1
1956 1
1957 1
1958 1
1959 1
1961 5
1962 2
1963 4
1964 4
1965 3
1966 10
1967 7
1968 11
1969 6
1970 6
1971 9
1972 12
1973 16
1974 7
1975 10
1976 15
1977 13
1978 12
1979 11
1980 3
1981 5
1982 8
1983 12
1984 10
1985 17
1986 15
1987 15
1988 16
1989 15
1990 11
1991 28
1992 32
1993 30
1994 30
1995 31
1996 28
1997 46
1998 41
1999 40
2000 64
2001 67
2002 61
2003 67
2004 97
2005 109
2006 124
2007 131
2008 170
2009 207
2010 244
2011 274
2012 335
2013 409
2014 453
2015 479
2016 506
2017 516
2018 554
2019 587
2020 696
2021 820
2022 800
2023 686
2024 709
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,684 results

Results by year

Filters applied: . Clear all
Page 1
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Shah NP, Bhatia R, Altman JK, Amaya M, Begna KH, Berman E, Chan O, Clements J, Collins RH, Curtin PT, DeAngelo DJ, Drazer M, Maness L, Metheny L, Mohan S, Moore JO, Oehler V, Pratz K, Pusic I, Rose MG, Shomali W, Smith BD, Styler M, Talpaz M, Tanaka TN, Tantravahi S, Thompson J, Tsai S, Vaughn J, Welborn J, Yang DT, Sundar H, Gregory K. Shah NP, et al. J Natl Compr Canc Netw. 2024 Feb;22(1):43-69. doi: 10.6004/jnccn.2024.0007. J Natl Compr Canc Netw. 2024. PMID: 38394770
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates.
Lee CH, Voss MH, Carlo MI, Chen YB, Zucker M, Knezevic A, Lefkowitz RA, Shapnik N, Dadoun C, Reznik E, Shah NJ, Owens CN, McHugh DJ, Aggen DH, Laccetti AL, Kotecha R, Feldman DR, Motzer RJ. Lee CH, et al. Among authors: shah nj. J Clin Oncol. 2022 Jul 20;40(21):2333-2341. doi: 10.1200/JCO.21.01944. Epub 2022 Mar 17. J Clin Oncol. 2022. PMID: 35298296 Free PMC article. Clinical Trial.
Response.
Shah NM, Apps C, Kaltsakas G, Madden-Scott S, Suh ES, D'Cruz RF, Arbane G, Patout M, Lhuillier E, Hart N, Murphy PB. Shah NM, et al. Chest. 2024 Apr;165(4):e130-e131. doi: 10.1016/j.chest.2023.12.027. Chest. 2024. PMID: 38599760 No abstract available.
Hepatorenal syndrome.
Shah N, Silva RG, Kowalski A, Desai C, Lerma E. Shah N, et al. Dis Mon. 2016 Oct;62(10):364-375. doi: 10.1016/j.disamonth.2016.05.009. Epub 2016 Jun 29. Dis Mon. 2016. PMID: 27372112 Review. No abstract available.
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells.
Lichtenstein DA, Schischlik F, Shao L, Steinberg SM, Yates B, Wang HW, Wang Y, Inglefield J, Dulau-Florea A, Ceppi F, Hermida LC, Stringaris K, Dunham K, Homan P, Jailwala P, Mirazee J, Robinson W, Chisholm KM, Yuan C, Stetler-Stevenson M, Ombrello AK, Jin J, Fry TJ, Taylor N, Highfill SL, Jin P, Gardner RA, Shalabi H, Ruppin E, Stroncek DF, Shah NN. Lichtenstein DA, et al. Among authors: shah nn. Blood. 2021 Dec 16;138(24):2469-2484. doi: 10.1182/blood.2021011898. Blood. 2021. PMID: 34525183 Free PMC article. Clinical Trial.
8,684 results